Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    18708615 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study
Condition: Diabetic Retinopathy
Interventions: Drug: ruboxistaurin;   Drug: placebo

Indicates status has not been verified in more than two years